Emergent BioSolutions (EBS)
Supplies naloxone sprays and government-procured medical countermeasures for public-health emergencies.
$6.88
After hours+0.13 (+1.93%)
At close$6.75(+3.05%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 89.30% | 45.79M shares | |
|---|---|---|---|
| 201 holders · as of Jun 30, 2026 | |||
| Insiders | 6.00% | 3.08M shares | |
| 18 holders · as of Aug 12, 2026 | |||
| Other | 4.70% | 2.41M shares | |
| remainder | |||
51.27M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
201 holders · 45.79M shares · 34 new positions · 105 increased · 62 reduced · 27 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 4.72M | 9.20% | +375.1K | Aug 7, 2026 |
| Dimensional Fund Advisors LP | 3.08M | 6.00% | +319.5K | Aug 11, 2026 |
| State Street Corp | 2.93M | 5.71% | +79.5K | Aug 7, 2026 |
| American Century Companies Inc | 2.77M | 5.40% | +344.7K | Aug 12, 2026 |
| Vanguard Capital Management LLC | 2.20M | 4.29% | −59.2K | Aug 13, 2026 |
| LSV Asset Management | 1.70M | 3.31% | +799.2K | Aug 6, 2026 |
| Acadian Asset Management LLC | 1.34M | 2.62% | −37.3K | Aug 13, 2026 |
| Geode Capital Management, LLC | 1.34M | 2.61% | +64.3K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.30% | 3.98M | 13G | Jul 17, 2025 |
| Oak Hill Advisors, L.P. | 6.39% | 3.61M | 13G | Nov 13, 2024 |
| American Century Investment Management, Inc.incl. American Century ETF Trust, Stowers Institute for Medical Research +1 more | 5.40% | 2.77M | 13G | Aug 14, 2026 |
| Dimensional Fund Advisors LP | 5.30% | 2.76M | 13G | Apr 9, 2026 |
| State Street Corporation | 5.10% | 2.70M | 13G | Feb 9, 2026 |
| Vanguard Capital Management | 5.04% | 2.61M | 13G | Apr 29, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 1, 2026 | Paul Anthony Williamsofficer: SVP, Products Business | Sale | 3,000 | $8.40 | 159,098 |
| May 1, 2026 | Kathryn C. Zoondirector | Sale · 2 lots | 17,202 | $8.40 | 79,941 |
| Apr 30, 2026 | Keith Katkindirector | Sale | 15,481 | $8.28 | 96,294 |
| May 1, 2026 | Donald W. DeGolyerdirector | Sale · 2 lots | 15,481 | $8.40 | 129,721 |
| May 1, 2026 | Sujata Tyagi Dayaldirector | Sale · 2 lots | 13,761 | $8.40 | 100,563 |
| Apr 1, 2026 | Paul Anthony Williamsofficer: SVP, Products Business | Sale | 4,000 | $8.44 | 62,681 |
| Dec 5, 2025 | Ronald Richarddirector | Sale · 2 lots | 21,984 | $11.97 | 98,417 |
| Nov 10, 2025 | Donald W. DeGolyerdirector | Sale | 17,801 | $10.54 | 119,858 |
| Nov 7, 2025 | Sujata Tyagi Dayaldirector | Sale | 8,552 | $10.00 | 88,980 |
| Oct 7, 2025 | Coleen Glessnerofficer: EVP, Quality & Ethics, and CPL | Sale | 30,608 | $10.00 | 144,319 |
House and Senate disclosures
Not reported.